Glucose intolerance, insulin resistance, visceral adiposity, and dyslipidemia are the key metabolic features of MetS that increase the risk of type 2 diabetes mellitus.23 In our study, Cfb−/− rats had reduced visceral but increased subcutaneous fat. The gene discussed is CFB; the disease is type 2 diabetes mellitus.